GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS CARRYING VALUE

			As of September 30, 2022			As of December 31, 2021
	Life		Carrying			Carrying
	(Years)		Amount			Amount
				(unaudited)
Asuragen acquisition:
Thyroid		9	$	8,519		$	8,519
RedPath acquisition:
Pancreas test		7		16,141			16,141
Barrett’s test		9		6,682			6,682
CLIA Lab		2.3		609			609
Total			$	31,951		$	31,951
Accumulated Amortization				(30,772	)		(29,819	)
Net Carrying Value			$	1,179		$	2,132

SCHEDULE OF FUTURE ESTIMATED AMORTIZATION EXPENSE

2022		2023		2024		2025		2026		Total
$	318	$	861	$	-	$	-	$	-	$	1,179

SCHEDULE OF GOODWILL CARRYING VALUE

The following table displays a roll forward of the carrying amount of goodwill from December 31, 2021 to September 30, 2022:

	Carrying
	Amount
Balance as of December 31, 2021	$	8,433
Impairment from sale of Pharma Solutions Business		(8,433	)
Balance as of September 30, 2022	$	-